Additional Information
Size: |
100 µl |
Target: |
TGF beta 1 |
Conjugate: |
Streptavidin |
Research Area: |
Cardiovascular System | Angiogenesis | Cardiovascular Growth Factors | TGF | Cancer | Cancer Metabolism | Response to Hypoxia |
Alternative Name: |
CED Antibody, DPD1 Antibody, LAP Antibody, Latency-associated peptide Antibody, Prepro transforming growth factor beta 1 Antibody, TGF beta 1 Antibody, TGF beta Antibody, TGF beta 1 protein Antibody, TGF-beta 1 protein Antibody, TGF-beta-1 Antibody, |
Category: |
Antibodies |
Product Type: |
Polyclonal Antibody |
Immunogen: |
Synthesized peptide derived from human TGF β1 antibody. |
Immunogen Species: |
Human |
Applications: |
WB, IHC, ELISA |
Host: |
Rabbit |
Isotype: |
IgG |
Species Reactivity: |
Human, Mouse, Rat |
Antibody Dilution: |
WB (1:1000), IHC (1:100), ELISA (1:5000); optimal dilutions for assays should be determined by the user. |
Purification: |
Peptide Affinity Purified |
Storage Buffer: |
PBS pH 7.4, 50% glycerol, 150mM NaCl, 0.02% sodium azide |
Concentration: |
N/A |
Specificity: |
Detects ~45kDa, endogenous levels of total TGF β1 protein. |
Storage: |
-20ºC |
Shipping: |
Blue Ice or 4ºC |
Certificate of Analysis: |
A 1:1000 dilution of SPC-1312 was sufficient for detection of TGF beta 1 in 10 µg of HepG2 cell lysates by ECL immunoblot analysis using Goat Anti-Rabbit IgG:HRP as the secondary antibody. |
Cellular Localization: |
Secreted |
Tissue Specificity: |
Highly expressed in bone. Abundantly expressed in articular cartilage and chondrocytes and is increased in osteoarthritis (OA). Colocalizes with ASPN in chondrocytes within OA lesions of articular cartilage. |
Accession Number: |
NP_000651.3 |
Gene ID: |
7040 |
Swiss-Prot: |
P01137 |
Field of Use: |
For in vitro research use only. |